WallStreetZenWallStreetZen

NASDAQ: RIGL
Rigel Pharmaceuticals Revenue

OverviewForecastEarningsRevenue
DividendOwnership
Rigel Pharmaceuticals revenue was $179.28M for the trailing 12 months ending Dec 31, 2024, with N/A growth year over year. Quarterly revenue for the quarter (Q4 2024) ending on Dec 31, 2024 was $57.6M, up 4.1% from last quarter. For the last reported fiscal year 2024 ending Dec 31, 2024, RIGL annual revenue was $179.3M, with 53.4% growth year-over-year.

RIGL past revenue growth

How has RIGL's revenue growth performed historically?

Company
53.38%
Industry
511.06%
Market
20.87%
RIGL's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Industry Performance
RIGL's revenue has grown faster... subscribe to Premium to read more.
Revenue Growth vs Market Performance
RIGL's revenue growth is accelerating... subscribe to Premium to read more.
Accelerating Revenue Growth Performance

RIGL revenue history

Current Revenue
$179.3M
Current Earnings
$17.5M
Current Profit Margin
9.8%

Be the first to know when RIGL announces revenue.

RIGL Revenue History By Year

RIGL Yearly RevenueRIGL RevenueRIGL ChangeRIGL Revenue Growth
2024-12-31$179.28M$62.40M+53.38%
2023-12-31$116.88M-$3.36M-2.79%
2022-12-31$120.24M-$28.99M-19.43%
2021-12-31$149.24M$40.62M+37.39%
2020-12-31$108.62M$49.33M+83.21%
2019-12-31$59.29M$14.78M+33.20%
2018-12-31$44.51M$40.03M+892.62%
2017-12-31$4.48M-$15.90M-78.00%
2016-12-31$20.38M-$8.51M-29.46%
2015-12-31$28.90M$20.65M+250.24%
2014-12-31$8.25M$1.10M+15.38%
2013-12-31$7.15M$4.90M+217.78%
2012-12-31$2.25M-$2.50M-52.63%
2011-12-31$4.75M-$120.25M-96.20%
2010-12-31$125.00M$124.25M+16,566.67%
2009-12-31$750.00kN/AN/A
2008-12-31$0.00-$12.60M-100.00%
2007-12-31$12.60M-$20.87M-62.36%
2006-12-31$33.47M$16.95M+102.55%
2005-12-31$16.53M$11.79M+249.17%
2004-12-31$4.73M-$6.32M-57.19%
2003-12-31$11.06M-$4.73M-29.98%
2002-12-31$15.79M$485.00k+3.17%
2001-12-31$15.30M$2.09M+15.77%
2000-12-31$13.22M$4.23M+47.13%
1999-12-31$8.98M$8.96M+31,985.71%
1998-12-31$28.00kN/AN/A
1997-12-31$0.00N/AN/A

1 of 2

Rigel Pharmaceuticals Revenue FAQ

What was RIGL's revenue last quarter?

On Invalid Date, Rigel Pharmaceuticals (NASDAQ: RIGL) reported Q4 2024 revenue of $57.60 million up 60.92% year over year. In the same quarter last year, Rigel Pharmaceuticals's revenue was $35.79 million.

What was Rigel Pharmaceuticals's revenue in 2024?

Rigel Pharmaceuticals's annual revenue for the twelve months ending Dec 31, 2024 was $179.28 million, a 53.38% increase year over year.

How much does Rigel Pharmaceuticals make in a day?

Based on Rigel Pharmaceuticals annual revenue for the past five years, RIGL makes an average of $369,456.99 per day.

What was Rigel Pharmaceuticals's annual revenue growth in the past year?

As of Q2 2025, Rigel Pharmaceuticals's revenue has grown 53.38% year over year. This is 457.68 percentage points lower than the US Biotechnology industry revenue growth rate of 511.06%. Rigel Pharmaceuticals's revenue in the past year totaled $179.28 million.

How much does Rigel Pharmaceuticals make in a year?

Rigel Pharmaceuticals's revenue by year for the past five years is:
  • Rigel Pharmaceuticals's revenue for the twelve months ending Dec 31, 2024 was $179.28 million, a 53.38% increase year over year.
  • Rigel Pharmaceuticals's annual revenue for Dec 31, 2023 was $116.88 million, a 2.79% decrease from 2022.
  • Rigel Pharmaceuticals's annual revenue for 2022 was $120.24 million, a 19.43% decrease from 2021.
  • Rigel Pharmaceuticals's annual revenue for 2021 was $149.24 million, a 37.39% increase from 2020.
  • Rigel Pharmaceuticals's annual revenue for 2020 was $108.62 million, a 83.21% increase from 2019.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.